421 related items for PubMed ID: 27878631
1. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
[Abstract] [Full Text] [Related]
2. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[Abstract] [Full Text] [Related]
3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 May; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
5. Association between maternal age and outcomes in Kawasaki disease patients.
Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
[Abstract] [Full Text] [Related]
6. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T, Sakakibara H, Morikawa Y, Miura M.
Pediatr Rheumatol Online J; 2015 Nov 04; 13(1):44. PubMed ID: 26530040
[Abstract] [Full Text] [Related]
7. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.
JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955
[Abstract] [Full Text] [Related]
8. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan 07; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
9. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
Sudo D, Monobe Y, Yashiro M, Sadakane A, Uehara R, Nakamura Y.
Pediatr Int; 2010 Oct 07; 52(5):790-4. PubMed ID: 20487371
[Abstract] [Full Text] [Related]
10. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 07; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
11. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
[Abstract] [Full Text] [Related]
12. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
Ther Apher Dial; 2015 Apr 15; 19(2):171-7. PubMed ID: 25257673
[Abstract] [Full Text] [Related]
13. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
Am Heart J; 2020 Jul 15; 225():120-128. PubMed ID: 32497905
[Abstract] [Full Text] [Related]
14. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F.
J Epidemiol; 2020 Oct 05; 30(10):429-435. PubMed ID: 31548437
[Abstract] [Full Text] [Related]
15. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 05; 14(12):938-41. PubMed ID: 23234782
[Abstract] [Full Text] [Related]
16. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.
Kuwabara M, Yashiro M, Ae R, Yanagawa H, Nakamura Y.
Int J Cardiol; 2018 Oct 15; 269():334-338. PubMed ID: 30049499
[Abstract] [Full Text] [Related]
17. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
Ruan Y, Ye B, Zhao X.
Pediatr Infect Dis J; 2013 Oct 15; 32(10):e397-402. PubMed ID: 23722531
[Abstract] [Full Text] [Related]
18. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
19. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 01; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
20. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
Pediatr Infect Dis J; 2008 Feb 01; 27(2):155-60. PubMed ID: 18174868
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
